Article info

PDF
Inhibition of plasma IL-6 in addition to maintenance of an efficacious trough level of infliximab associated with clinical remission in patients with rheumatoid arthritis: analysis of the RISING Study

Authors

  1. Correspondence to Tsutomu Takeuchi; Division of Rheumatology, Department of Internal Medicine, School of Medicine, Keio University, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan; tsutake{at}z5.keio.jp
View Full Text

Citation

Takeuchi T, Miyasaka N, Tatsuki Y, et al
Inhibition of plasma IL-6 in addition to maintenance of an efficacious trough level of infliximab associated with clinical remission in patients with rheumatoid arthritis: analysis of the RISING Study

Publication history

  • Accepted 25 February 2012
  • Published in print 1 September 2012.
  • Published online 8 August 2012.
  • Published first 5 May 2012.

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.